Skip to main content

Table 2 Difference in rate of change per year of FVC, DLCO, and 6MWD per covariate in patients with CTD-ILD

From: Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study

Variable

FVC

DLCO

6MWD

Unadjusted analysis

Multivariable analysis

Unadjusted analysis

Multivariable analysis

Unadjusted analysis

Multivariable analysis

Difference in rate of change (95% CI)

p

Difference in rate of change (95% CI)

p

Difference in rate of change (95% CI)

p

Difference in rate of change (95% CI)

p

Difference in rate of change (95% CI)

p

Difference in rate of change (95% CI)

p

Overall change per year

− 1.4 (− 1.8, − 0.9)

< 0.001

–

–

− 1.8 (− 2.2, − 1.4)

< 0.001

–

–

−9.9 (− 16.0, − 3.8)

0.002

–

–

Age per 10y increasea

− 0.2 (− 0.6, 0.1)

0.16

− 0.1 (− 0.5, 0.3)

0.62

− 0.4 (− 0.7, 0.0)

0.03

− 0.3 (− 0.7, 0.0)

0.08

−4.5 (− 9.5, 0.5)

0.08

− 3.1 (−8.6, 2.3)

0.26

Male vs. female

− 1.7 (− 2.7, − 0.7)

< 0.001

− 1.9 (− 3.0, − 0.8)

< 0.001

− 1.1 (− 2.1, − 0.1)

0.03

− 1.3 (− 2.4, − 0.3)

0.02

− 26.6 (− 41.0, − 12.2)

< 0.001

− 28.6 (− 44.5, − 12.6)

< 0.001

Ethnicity

 Caucasian vs. non-Caucasian

−0.4 (− 1.3, 0.5)

0.40

0.1 (− 1.0, 1.2)

0.86

− 0.5 (− 1.4, 0.5)

0.31

0.4 (− 0.7, 1.5)

0.46

−5.0 (− 21.1, 11.2)

0.55

− 8.8 (− 26.1, 8.4)

0.32

 EA vs. non-EA

0.5 (− 0.6, 1.7)

0.37

0.5 (− 0.8, 1.8)

0.44

0.5 (− 0.7, 1.7)

0.40

0.1 (− 1.2, 1.3)

0.92

0.5 (− 18.9, 20.0)

0.96

− 1.7 (− 21.6, 18.3)

0.87

 SA vs. non-SA

− 1.7 (− 3.3, − 0.1)

0.04

−2.3 (− 4.0, 0.5)

0.010

−0.7 (− 2.4, 1.0)

0.43

−1.9 (− 3.7, − 0.1)

0.04

0.8 (− 24.1, 25.7)

0.95

− 11.6 (− 38.2, 14.9)

0.39

 FN vs. non-FN

1.5 (− 0.4, 3.3)

0.12

0.8 (− 1.2, 2.8)

0.44

0.5 (− 1.3, 2.2)

0.60

0.2 (− 1.7, 2.1)

0.86

0.9 (− 34.3, 36.2)

0.96

5.6 (− 32.0, 43.2)

0.77

Pos. vs. neg. Smoking

− 0.2 (− 1.1, 0.6)

0.61

−0.2 (− 1.1, 0.8)

0.75

−1.0 (− 1.8, − 0.2)

0.02

−1.1 (− 2.0, − 0.2)

0.02

−0.4 (− 12.6, 11.8)

0.95

3.7 (− 10.2, 17.6)

0.60

Income per 10 K increase

−0.2 (− 0.4, 0.0)

0.02

− 0.1 (− 0.3, 0.1)

0.20

−0.1 (− 0.3, 0.0)

0.14

−0.1 (− 0.2, 0.1)

0.55

−1.7 (− 4.3, 1.0)

0.21

−0.2 (− 3.1, 2.7)

0.90

CTD subtype

 SSc vs. RA

0.3 (−1.1, 1.7)

0.67

−0.1 (− 2.0, 1.7)

0.90

0.2 (−1.2, 1.6)

0.76

−0.1 (− 2.0, 1.8)

0.93

18.2 (− 12.2, 48.6)

0.24

18.6 (−22.4, 59.5)

0.37

 SSc vs. MCTD

0.0 (−1.7, 1.7)

0.99

0.1 (−1.8, 1.9)

0.96

−0.6 (−2.2, 0.9)

0.43

−0.8 (−2.5, 1.0)

0.40

−17.7 (− 43.0, 7.6)

0.17

− 18.7 (− 45.4, 7.9)

0.17

 SSc vs. other CTD

− 1.0 (− 2.1, 0.1)

0.08

−1.8 (− 3.1, − 0.5)

0.006

−1.5 (− 2.6, − 0.4)

0.007

−2.0 (− 3.2, − 0.7)

0.002

−9.0 (− 31.0, 13.1)

0.43

−23.3 (− 47.9, 1.2)

0.06

Baseline valuea (per 10%-predicted / 100 m decrease)

0.0 (− 0.2, 0.2)

0.93

0.1 (− 0.2, 0.3)

0.69

0.2 (0.0, 0.4)

0.09

0.2 (− 0.1, 0.4)

0.14

2.5 (−3.2, 8.3)

0.39

3.5 (−2.8, 9.8)

0.28

UIP vs. NSIP

−0.9 (−2.4, 0.6)

0.23

− 0.7 (− 2.3, 0.9)

0.39

0.1 (− 1.4, 1.6)

0.88

0.6 (− 1.1, 2.2)

0.49

− 28.9 (− 50.7, − 7.0)

0.010

− 24.2 (− 46.9, − 1.5)

0.04

  1. FVC forced vital capacity; DLCO diffusing capacity of lungs for carbon monoxide, 6MWD six-minute walk distance, EA East Asian, SA South Asian, FN First Nations, SSc systemic sclerosis, RA rheumatoid arthritis, MCTD mixed connective tissue disease, CTD connective tissue disease, UIP usual interstitial pneumonia, NSIP non-specific interstitial pneumonia
  2. Multivariable analyses performed using linear mixed effects models were adjusted for sex, age, ethnicity, estimated income, smoking history, CTD subtype, radiographic pattern, anti-nuclear antibody status, baseline FVC/DLCO/6MWD
  3. aModelled as continuous variables but reported in increments of 10 years (age), 10%-predicted (FVC, DLCO), 100 m (6MWD) for illustrative purposes